Palisade Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
FFM
ZIC
Palisade Asset Management's BSX Position: Q2 2026 in Review
Palisade Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,626 shares — an estimated $228K sold.
Palisade Asset Management first reported a position in BSX in Q1 2015 and held it in 18 quarters. The position peaked at $388K in Q2 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Palisade Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Palisade Asset Management sold 3,626 Boston Scientific shares in Q2 2026, an estimated $228K.
- Palisade Asset Management first reported a position in Boston Scientific in Q1 2015 and held it in 18 quarters.
- Palisade Asset Management's Boston Scientific position peaked at $388K in Q2 2025.
- 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.